The global market for Candesartan and Hydrochlorothiazide was estimated to be worth US$ 303 million in 2023 and is forecast to a readjusted size of US$ 470.1 million by 2030 with a CAGR of 6.4% during the forecast period 2024-2030

Candesartan and Hydrochlorothiazide - Market

Candesartan and Hydrochlorothiazide contains 2 medications: candesartan and hydrochlorothiazide. Candesartan belongs to a family of medications known as angiotensin II receptor blockers. Hydrochlorothiazide belongs to a family of medications known as diuretics (or "water pills"). This combination medication is used to lower high blood pressure.

North American market for Candesartan and Hydrochlorothiazide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Candesartan and Hydrochlorothiazide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Candesartan and Hydrochlorothiazide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Candesartan and Hydrochlorothiazide include AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical and MACLEODS, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Candesartan and Hydrochlorothiazide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Candesartan and Hydrochlorothiazide by region & country, by Type, and by Application.

The Candesartan and Hydrochlorothiazide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candesartan and Hydrochlorothiazide.

Market Segmentation

Scope of Candesartan and Hydrochlorothiazide - Market Report

Report Metric	Details
Report Name	Candesartan and Hydrochlorothiazide - Market
Forecasted market size in 2030	US$ 470.1 million
CAGR	6.4%
Forecasted years	2024 - 2030
Segment by Type:	16/12.5 32/12.5 32/25
Segment by Application	Adults Geriatric
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical, MACLEODS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Candesartan and Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Candesartan and Hydrochlorothiazide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Candesartan and Hydrochlorothiazide in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Candesartan and Hydrochlorothiazide - Market size in 2030?

Ans: The Candesartan and Hydrochlorothiazide - Market size in 2030 will be US$ 470.1 million.

Who are the main players in the Candesartan and Hydrochlorothiazide - Market report?

Ans: The main players in the Candesartan and Hydrochlorothiazide - Market are AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical, MACLEODS

What are the Application segmentation covered in the Candesartan and Hydrochlorothiazide - Market report?

Ans: The Applications covered in the Candesartan and Hydrochlorothiazide - Market report are Adults, Geriatric

What are the Type segmentation covered in the Candesartan and Hydrochlorothiazide - Market report?

Ans: The Types covered in the Candesartan and Hydrochlorothiazide - Market report are 16/12.5, 32/12.5, 32/25

1 Market Overview

1.1 Candesartan and Hydrochlorothiazide Product Introduction

1.2 Global Candesartan and Hydrochlorothiazide Market Size Forecast

1.2.1 Global Candesartan and Hydrochlorothiazide Sales Value (2019-2030)

1.2.2 Global Candesartan and Hydrochlorothiazide Sales Volume (2019-2030)

1.2.3 Global Candesartan and Hydrochlorothiazide Sales Price (2019-2030)

1.3 Candesartan and Hydrochlorothiazide Market Trends & Drivers

1.3.1 Candesartan and Hydrochlorothiazide Industry Trends

1.3.2 Candesartan and Hydrochlorothiazide Market Drivers & Opportunity

1.3.3 Candesartan and Hydrochlorothiazide Market Challenges

1.3.4 Candesartan and Hydrochlorothiazide Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Candesartan and Hydrochlorothiazide Players Revenue Ranking (2023)

2.2 Global Candesartan and Hydrochlorothiazide Revenue by Company (2019-2024)

2.3 Global Candesartan and Hydrochlorothiazide Players Sales Volume Ranking (2023)

2.4 Global Candesartan and Hydrochlorothiazide Sales Volume by Company Players (2019-2024)

2.5 Global Candesartan and Hydrochlorothiazide Average Price by Company (2019-2024)

2.6 Key Manufacturers Candesartan and Hydrochlorothiazide Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Candesartan and Hydrochlorothiazide Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Candesartan and Hydrochlorothiazide

2.9 Candesartan and Hydrochlorothiazide Market Competitive Analysis

2.9.1 Candesartan and Hydrochlorothiazide Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Candesartan and Hydrochlorothiazide Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candesartan and Hydrochlorothiazide as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 16/12.5

3.1.2 32/12.5

3.1.3 32/25

3.2 Global Candesartan and Hydrochlorothiazide Sales Value by Type

3.2.1 Global Candesartan and Hydrochlorothiazide Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Candesartan and Hydrochlorothiazide Sales Value, by Type (2019-2030)

3.2.3 Global Candesartan and Hydrochlorothiazide Sales Value, by Type (%) (2019-2030)

3.3 Global Candesartan and Hydrochlorothiazide Sales Volume by Type

3.3.1 Global Candesartan and Hydrochlorothiazide Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Candesartan and Hydrochlorothiazide Sales Volume, by Type (2019-2030)

3.3.3 Global Candesartan and Hydrochlorothiazide Sales Volume, by Type (%) (2019-2030)

3.4 Global Candesartan and Hydrochlorothiazide Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Adults

4.1.2 Geriatric

4.2 Global Candesartan and Hydrochlorothiazide Sales Value by Application

4.2.1 Global Candesartan and Hydrochlorothiazide Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Candesartan and Hydrochlorothiazide Sales Value, by Application (2019-2030)

4.2.3 Global Candesartan and Hydrochlorothiazide Sales Value, by Application (%) (2019-2030)

4.3 Global Candesartan and Hydrochlorothiazide Sales Volume by Application

4.3.1 Global Candesartan and Hydrochlorothiazide Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Candesartan and Hydrochlorothiazide Sales Volume, by Application (2019-2030)

4.3.3 Global Candesartan and Hydrochlorothiazide Sales Volume, by Application (%) (2019-2030)

4.4 Global Candesartan and Hydrochlorothiazide Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Candesartan and Hydrochlorothiazide Sales Value by Region

5.1.1 Global Candesartan and Hydrochlorothiazide Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Candesartan and Hydrochlorothiazide Sales Value by Region (2019-2024)

5.1.3 Global Candesartan and Hydrochlorothiazide Sales Value by Region (2025-2030)

5.1.4 Global Candesartan and Hydrochlorothiazide Sales Value by Region (%), (2019-2030)

5.2 Global Candesartan and Hydrochlorothiazide Sales Volume by Region

5.2.1 Global Candesartan and Hydrochlorothiazide Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Candesartan and Hydrochlorothiazide Sales Volume by Region (2019-2024)

5.2.3 Global Candesartan and Hydrochlorothiazide Sales Volume by Region (2025-2030)

5.2.4 Global Candesartan and Hydrochlorothiazide Sales Volume by Region (%), (2019-2030)

5.3 Global Candesartan and Hydrochlorothiazide Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

5.4.2 North America Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

5.5.2 Europe Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

5.6.2 Asia Pacific Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

5.7.2 South America Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

5.8.2 Middle East & Africa Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Value

6.2.1 Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

6.2.2 Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

6.3.2 United States Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Candesartan and Hydrochlorothiazide Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

6.4.2 Europe Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Candesartan and Hydrochlorothiazide Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

6.5.2 China Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

6.5.3 China Candesartan and Hydrochlorothiazide Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

6.6.2 Japan Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Candesartan and Hydrochlorothiazide Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

6.7.2 South Korea Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Candesartan and Hydrochlorothiazide Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

6.8.2 Southeast Asia Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Candesartan and Hydrochlorothiazide Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Candesartan and Hydrochlorothiazide Sales Value, 2019-2030

6.9.2 India Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

6.9.3 India Candesartan and Hydrochlorothiazide Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AstraZeneca

7.1.1 AstraZeneca Company Information

7.1.2 AstraZeneca Introduction and Business Overview

7.1.3 AstraZeneca Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)

7.1.4 AstraZeneca Candesartan and Hydrochlorothiazide Product Offerings

7.1.5 AstraZeneca Recent Development

7.2 ANI Pharmaceuticals

7.2.1 ANI Pharmaceuticals Company Information

7.2.2 ANI Pharmaceuticals Introduction and Business Overview

7.2.3 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)

7.2.4 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Offerings

7.2.5 ANI Pharmaceuticals Recent Development

7.3 TEVA

7.3.1 TEVA Company Information

7.3.2 TEVA Introduction and Business Overview

7.3.3 TEVA Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)

7.3.4 TEVA Candesartan and Hydrochlorothiazide Product Offerings

7.3.5 TEVA Recent Development

7.4 Mylan

7.4.1 Mylan Company Information

7.4.2 Mylan Introduction and Business Overview

7.4.3 Mylan Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Mylan Candesartan and Hydrochlorothiazide Product Offerings

7.4.5 Mylan Recent Development

7.5 Dr. Reddy's Laboratories

7.5.1 Dr. Reddy's Laboratories Company Information

7.5.2 Dr. Reddy's Laboratories Introduction and Business Overview

7.5.3 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Offerings

7.5.5 Dr. Reddy's Laboratories Recent Development

7.6 Zydus Pharmaceuticals

7.6.1 Zydus Pharmaceuticals Company Information

7.6.2 Zydus Pharmaceuticals Introduction and Business Overview

7.6.3 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Offerings

7.6.5 Zydus Pharmaceuticals Recent Development

7.7 Prinston Pharmaceutical

7.7.1 Prinston Pharmaceutical Company Information

7.7.2 Prinston Pharmaceutical Introduction and Business Overview

7.7.3 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Offerings

7.7.5 Prinston Pharmaceutical Recent Development

7.8 MACLEODS

7.8.1 MACLEODS Company Information

7.8.2 MACLEODS Introduction and Business Overview

7.8.3 MACLEODS Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)

7.8.4 MACLEODS Candesartan and Hydrochlorothiazide Product Offerings

7.8.5 MACLEODS Recent Development

8 Industry Chain Analysis

8.1 Candesartan and Hydrochlorothiazide Industrial Chain

8.2 Candesartan and Hydrochlorothiazide Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Candesartan and Hydrochlorothiazide Sales Model

8.5.2 Sales Channel

8.5.3 Candesartan and Hydrochlorothiazide Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Zydus Pharmaceuticals

Prinston Pharmaceutical

Macleods

List of Tables

Table 1. Candesartan and Hydrochlorothiazide Market Trends

Table 2. Candesartan and Hydrochlorothiazide Market Drivers & Opportunity

Table 3. Candesartan and Hydrochlorothiazide Market Challenges

Table 4. Candesartan and Hydrochlorothiazide Market Restraints

Table 5. Global Candesartan and Hydrochlorothiazide Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Company (2019-2024)

Table 7. Global Candesartan and Hydrochlorothiazide Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Candesartan and Hydrochlorothiazide Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Candesartan and Hydrochlorothiazide Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Candesartan and Hydrochlorothiazide Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Candesartan and Hydrochlorothiazide Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Candesartan and Hydrochlorothiazide

Table 13. Global Candesartan and Hydrochlorothiazide Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candesartan and Hydrochlorothiazide as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Candesartan and Hydrochlorothiazide Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Candesartan and Hydrochlorothiazide Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Candesartan and Hydrochlorothiazide Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Candesartan and Hydrochlorothiazide Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Candesartan and Hydrochlorothiazide Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Candesartan and Hydrochlorothiazide Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Candesartan and Hydrochlorothiazide Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Candesartan and Hydrochlorothiazide Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Candesartan and Hydrochlorothiazide Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Candesartan and Hydrochlorothiazide Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Candesartan and Hydrochlorothiazide Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Candesartan and Hydrochlorothiazide Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Candesartan and Hydrochlorothiazide Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Candesartan and Hydrochlorothiazide Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Candesartan and Hydrochlorothiazide Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Candesartan and Hydrochlorothiazide Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Candesartan and Hydrochlorothiazide Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Candesartan and Hydrochlorothiazide Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Candesartan and Hydrochlorothiazide Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Candesartan and Hydrochlorothiazide Sales Value by Region (2019-2024) & (%)

Table 44. Global Candesartan and Hydrochlorothiazide Sales Value by Region (2025-2030) & (%)

Table 45. Global Candesartan and Hydrochlorothiazide Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Candesartan and Hydrochlorothiazide Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Candesartan and Hydrochlorothiazide Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Candesartan and Hydrochlorothiazide Sales Volume by Region (2019-2024) & (%)

Table 49. Global Candesartan and Hydrochlorothiazide Sales Volume by Region (2025-2030) & (%)

Table 50. Global Candesartan and Hydrochlorothiazide Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Candesartan and Hydrochlorothiazide Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Volume, (2025-2030) & (K Units)

Table 57. AstraZeneca Company Information

Table 58. AstraZeneca Introduction and Business Overview

Table 59. AstraZeneca Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. AstraZeneca Candesartan and Hydrochlorothiazide Product Offerings

Table 61. AstraZeneca Recent Development

Table 62. ANI Pharmaceuticals Company Information

Table 63. ANI Pharmaceuticals Introduction and Business Overview

Table 64. ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Offerings

Table 66. ANI Pharmaceuticals Recent Development

Table 67. TEVA Company Information

Table 68. TEVA Introduction and Business Overview

Table 69. TEVA Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. TEVA Candesartan and Hydrochlorothiazide Product Offerings

Table 71. TEVA Recent Development

Table 72. Mylan Company Information

Table 73. Mylan Introduction and Business Overview

Table 74. Mylan Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Mylan Candesartan and Hydrochlorothiazide Product Offerings

Table 76. Mylan Recent Development

Table 77. Dr. Reddy's Laboratories Company Information

Table 78. Dr. Reddy's Laboratories Introduction and Business Overview

Table 79. Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Offerings

Table 81. Dr. Reddy's Laboratories Recent Development

Table 82. Zydus Pharmaceuticals Company Information

Table 83. Zydus Pharmaceuticals Introduction and Business Overview

Table 84. Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Offerings

Table 86. Zydus Pharmaceuticals Recent Development

Table 87. Prinston Pharmaceutical Company Information

Table 88. Prinston Pharmaceutical Introduction and Business Overview

Table 89. Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Offerings

Table 91. Prinston Pharmaceutical Recent Development

Table 92. MACLEODS Company Information

Table 93. MACLEODS Introduction and Business Overview

Table 94. MACLEODS Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. MACLEODS Candesartan and Hydrochlorothiazide Product Offerings

Table 96. MACLEODS Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Candesartan and Hydrochlorothiazide Downstream Customers

Table 100. Candesartan and Hydrochlorothiazide Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Candesartan and Hydrochlorothiazide Product Picture

Figure 2. Global Candesartan and Hydrochlorothiazide Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Candesartan and Hydrochlorothiazide Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Candesartan and Hydrochlorothiazide Sales Volume (2019-2030) & (K Units)

Figure 5. Global Candesartan and Hydrochlorothiazide Sales Price (2019-2030) & (USD/Unit)

Figure 6. Candesartan and Hydrochlorothiazide Report Years Considered

Figure 7. Global Candesartan and Hydrochlorothiazide Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Candesartan and Hydrochlorothiazide Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Candesartan and Hydrochlorothiazide Revenue in 2023

Figure 10. Candesartan and Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 16/12.5 Picture

Figure 12. 32/12.5 Picture

Figure 13. 32/25 Picture

Figure 14. Global Candesartan and Hydrochlorothiazide Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Candesartan and Hydrochlorothiazide Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Candesartan and Hydrochlorothiazide Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Candesartan and Hydrochlorothiazide Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Candesartan and Hydrochlorothiazide Price by Type (2019-2030) & (USD/Unit)

Figure 19. Product Picture of Adults

Figure 20. Product Picture of Geriatric

Figure 21. Global Candesartan and Hydrochlorothiazide Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Candesartan and Hydrochlorothiazide Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Candesartan and Hydrochlorothiazide Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Candesartan and Hydrochlorothiazide Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Candesartan and Hydrochlorothiazide Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Candesartan and Hydrochlorothiazide Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Candesartan and Hydrochlorothiazide Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Candesartan and Hydrochlorothiazide Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Candesartan and Hydrochlorothiazide Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Candesartan and Hydrochlorothiazide Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Candesartan and Hydrochlorothiazide Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Candesartan and Hydrochlorothiazide Sales Volume (%), (2019-2030)

Figure 38. United States Candesartan and Hydrochlorothiazide Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Candesartan and Hydrochlorothiazide Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Candesartan and Hydrochlorothiazide Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Candesartan and Hydrochlorothiazide Sales Value by Application (%), 2023 VS 2030

Figure 44. China Candesartan and Hydrochlorothiazide Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

Figure 46. China Candesartan and Hydrochlorothiazide Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Candesartan and Hydrochlorothiazide Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Candesartan and Hydrochlorothiazide Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Candesartan and Hydrochlorothiazide Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Candesartan and Hydrochlorothiazide Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Candesartan and Hydrochlorothiazide Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Candesartan and Hydrochlorothiazide Sales Value by Application (%), 2023 VS 2030

Figure 56. India Candesartan and Hydrochlorothiazide Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Candesartan and Hydrochlorothiazide Sales Value by Type (%), 2023 VS 2030

Figure 58. India Candesartan and Hydrochlorothiazide Sales Value by Application (%), 2023 VS 2030

Figure 59. Candesartan and Hydrochlorothiazide Industrial Chain

Figure 60. Candesartan and Hydrochlorothiazide Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions